Investigation of Association of Complement 5 Genetic Polymorphisms with Sepsis and Sepsis-Induced Inflammatory Responses

References

• Hotchkiss RS, Sherwood ER. Immunology. Getting sepsis therapy right. Science. 2015;347(6227):1201–1202. doi:10.1126/science.aaa8334
   PubMed Web of Science ®Google Scholar
• Bosurgi R. Sepsis: a need for new solutions. Lancet Infect Dis. 2015;15(5):498–499. doi:10.1016/S1473-3099(15)70030-7
   PubMed Web of Science ®Google Scholar
• Cohen J, Vincent JL, Adhikari NK, et al. Sepsis: a roadmap for future research. Lancet Infect Dis. 2015;15:581–614. doi:10.1016/S1473-3099(15)70112-X
   PubMed Web of Science ®Google Scholar
• Lu H, Wen D, Wang X, et al. Host genetic variants in sepsis risk: a field synopsis and meta-analysis. Crit Care. 2019;23(1):26. doi:10.1186/s13054-019-2313-0
   PubMedGoogle Scholar
• Lu F, Chen H, Hong Y, et al. A gain-of-function NLRP3 3’-UTR polymorphism causes miR-146a-mediated suppression of NLRP3 expression and confers protection against sepsis progression. Sci Rep. 2021;11(1):13300. doi:10.1038/s41598-021-92547-8
   PubMed Web of Science ®Google Scholar
• He J, Chen Y, Lin Y, et al. Association study of MCP-1 promoter polymorphisms with the susceptibility and progression of sepsis. PLoS One. 2017;12(5):e0176781. doi:10.1371/journal.pone.0176781
   PubMed Web of Science ®Google Scholar
• He J, Zhang Q, Zhang W, et al. The interleukin-27-964A>G polymorphism enhances sepsis-induced inflammatory responses and confers susceptibility to the development of sepsis. Crit Care. 2018;22(1):248. doi:10.1186/s13054-018-2180-0
   PubMedGoogle Scholar
• Romano R, Giardino G, Cirillo E, Prencipe R, Pignata C. Complement system network in cell physiology and in human diseases. Int Rev Immunol. 2021;40(3):159–170. doi:10.1080/08830185.2020.1833877
   PubMed Web of Science ®Google Scholar
• Guo RF, Ward PA. Role of C5a in inflammatory responses. Annu Rev Immunol. 2005;23:821–852. doi:10.1146/annurev.immunol.23.021704.115835
   PubMed Web of Science ®Google Scholar
• Zetoune FS, Ward PA. Role of complement and histones in sepsis. Front Med. 2020;7:616957. doi:10.3389/fmed.2020.616957
   PubMed Web of Science ®Google Scholar
• Ward PA. The dark side of C5a in sepsis. Nat Rev Immunol. 2004;4(2):133–142. doi:10.1038/nri1269
   PubMed Web of Science ®Google Scholar
• Helling H, Stephan B, Pindur G, Prantl L, Jung EM, Jung F. Coagulation and complement system in critically ill patients. Clin Hemorheol Microcirc. 2015;61(2):185–193. doi:10.3233/CH-151993
   PubMed Web of Science ®Google Scholar
• Fischer MB, Prodeus AP, Nicholson-Weller A, et al. Increased susceptibility to endotoxin shock in complement C3- and C4-deficient mice is corrected by C1 inhibitor replacement. J Immunol. 1997;159(2):976–982.
   PubMed Web of Science ®Google Scholar
• Prodeus AP, Zhou X, Maurer M, Galli SJ, Carroll MC. Impaired mast cell-dependent natural immunity in complement C3-deficient mice. Nature. 1997;390(6656):172–175. doi:10.1038/36586
   PubMed Web of Science ®Google Scholar
• Buras JA, Rice L, Orlow D, et al. Inhibition of C5 or absence of C6 protects from sepsis mortality. Immunobiology. 2004;209(8):629–635. doi:10.1016/j.imbio.2004.09.004
   PubMed Web of Science ®Google Scholar
• Hangen DH, Bloom RJ, Stevens JH, et al. Adult respiratory distress syndrome. A live E coli septic primate model. Am J Pathol. 1987;126:396–400.
   PubMed Web of Science ®Google Scholar
• Stevens JH, O’Hanley P, Shapiro JM, et al. Effects of anti-C5a antibodies on the adult respiratory distress syndrome in septic primates. J Clin Invest. 1986;77:1812–1816. doi:10.1172/JCI112506
   PubMed Web of Science ®Google Scholar
• Nieuwenhuijzen GA, Meyer MP, Hendriks T, Goris RJ. Deficiency of complement factor C5 reduces early mortality but does not prevent organ damage in an animal model of multiple organ dysfunction syndrome. Crit Care Med. 1995;23(10):1686–1693. doi:10.1097/00003246-199510000-00013
   PubMed Web of Science ®Google Scholar
• Keshari RS, Silasi R, Popescu NI, et al. Inhibition of complement C5 protects against organ failure and reduces mortality in a baboon model of Escherichia coli sepsis. Proc Natl Acad Sci U S A. 2017;114(31):E6390–E6399. doi:10.1073/pnas.1706818114
   PubMed Web of Science ®Google Scholar
• Czermak BJ, Sarma V, Pierson CL, et al. Protective effects of C5a blockade in sepsis. Nat Med. 1999;5(7):788–792. doi:10.1038/10512
   PubMed Web of Science ®Google Scholar
• Ward PA. The harmful role of c5a on innate immunity in sepsis. J Innate Immun. 2010;2(5):439–445. doi:10.1159/000317194
   PubMed Web of Science ®Google Scholar
• Harris CL, Heurich M, Rodriguez de Cordoba S, Morgan BP. The complotype: dictating risk for inflammation and infection. Trends Immunol. 2012;33(10):513–521. doi:10.1016/j.it.2012.06.001
   PubMed Web of Science ®Google Scholar
• Arnaout R, Al Shorbaghi S, Al Dhekri H, et al. C5 complement deficiency in a Saudi family, molecular characterization of mutation and literature review. J Clin Immunol. 2013;33(4):871–875. doi:10.1007/s10875-013-9872-7
   PubMed Web of Science ®Google Scholar
• Zervou MI, Vazgiourakis VM, Yilmaz N, et al. TRAF1/C5, eNOS, C1q, but not STAT4 and PTPN22 gene polymorphisms are associated with genetic susceptibility to systemic lupus erythematosus in Turkey. Hum Immunol. 2011;72(12):1210–1213. doi:10.1016/j.humimm.2011.09.003
   PubMed Web of Science ®Google Scholar
• Huang SC, Hua DJ, Sun QQ, Zhang LN, Cen H, Zhou L. Associations of TRAF1/C5 rs10818488 and rs3761847 polymorphisms with genetic susceptibility to rheumatoid arthritis: a case-control study and updated meta-analysis. Cent Eur J Immunol. 2019;44(2):159–173. doi:10.5114/ceji.2019.87067
   PubMed Web of Science ®Google Scholar
• Xu D, Yi H, Yu S, Li X, Qiao Y, Deng W. Association of complement C5 gene polymorphisms with proliferative diabetic retinopathy of type 2 diabetes in a Chinese Han Population. PLoS One. 2016;11(3):e0149704. doi:10.1371/journal.pone.0149704
   PubMed Web of Science ®Google Scholar
• Giles JL, Choy E, van den Berg C, Morgan BP, Harris CL. Functional analysis of a complement polymorphism (rs17611) associated with rheumatoid arthritis. J Immunol. 2015;194(7):3029–3034. doi:10.4049/jimmunol.1402956
   PubMed Web of Science ®Google Scholar
• Guo L, Zheng L, Guo X, Chang Y, Zhou X, Sun Y. Single-nucleotide polymorphism rs17611 of complement component 5 shows association with ischemic stroke in Northeast Chinese Population. Genet Test Mol Biomarkers. 2016;20(12):766–770. doi:10.1089/gtmb.2016.0125
   PubMed Web of Science ®Google Scholar
• Woehrl B, Brouwer MC, Murr C, et al. Complement component 5 contributes to poor disease outcome in humans and mice with pneumococcal meningitis. J Clin Invest. 2011;121(10):3943–3953. doi:10.1172/JCI57522
   PubMed Web of Science ®Google Scholar
• Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA. 2016;315(8):801–810. doi:10.1001/jama.2016.0287
   PubMed Web of Science ®Google Scholar
• Zhang W, Lu F, Xie Y, et al. miR-23b negatively regulates sepsis-induced inflammatory responses by targeting ADAM10 in human THP-1 monocytes. Mediators Inflamm. 2019;2019:5306541. doi:10.1155/2019/5306541
   PubMed Web of Science ®Google Scholar
• Schaeffer V, Cuschieri J, Garcia I, et al. The priming effect of C5a on monocytes is predominantly mediated by the p38 MAPK pathway. Shock. 2018;50(1):127.
   PubMed Web of Science ®Google Scholar
• Gotts JE, Matthay MA. Sepsis: pathophysiology and clinical management. BMJ. 2016;353:i1585. doi:10.1136/bmj.i1585
   PubMed Web of Science ®Google Scholar
• Hajishengallis G, Reis ES, Mastellos DC, Ricklin D, Lambris JD. Novel mechanisms and functions of complement. Nat Immunol. 2017;18(12):1288–1298. doi:10.1038/ni.3858
   PubMed Web of Science ®Google Scholar
• Mollnes TE, Huber-Lang M. Complement in sepsis-when science meets clinics. FEBS Lett. 2020;594(16):2621–2632. doi:10.1002/1873-3468.13881
   PubMed Web of Science ®Google Scholar
• Reis ES, Mastellos DC, Hajishengallis G, Lambris JD. New insights into the immune functions of complement. Nat Rev Immunol. 2019;19(8):503–516. doi:10.1038/s41577-019-0168-x
   PubMed Web of Science ®Google Scholar
• Riedemann NC, Guo RF, Ward PA. A key role of C5a/C5aR activation for the development of sepsis. J Leukoc Biol. 2003;74(6):966–970. doi:10.1189/jlb.0403137
   PubMed Web of Science ®Google Scholar
• Hoehlig K, Maasch C, Shushakova N, et al. A novel C5a-neutralizing mirror-image (l-)aptamer prevents organ failure and improves survival in experimental sepsis. Mol Ther. 2013;21(12):2236–2246. doi:10.1038/mt.2013.178
   PubMed Web of Science ®Google Scholar
• Rittirsch D, Flierl MA, Nadeau BA, et al. Functional roles for C5a receptors in sepsis. Nat Med. 2008;14(5):551–557. doi:10.1038/nm1753
   PubMed Web of Science ®Google Scholar
• Vollrath JT, Marzi I, Herminghaus A, Lustenberger T, Relja B. Post-traumatic sepsis is associated with increased C5a and decreased TAFI levels. J Clin Med. 2020;9(4):1230. doi:10.3390/jcm9041230
   PubMed Web of Science ®Google Scholar
• Gressner OA, Koch A, Sanson E, Trautwein C, Tacke F. High C5a levels are associated with increased mortality in sepsis patients–no enhancing effect by actin-free Gc-globulin. Clin Biochem. 2008;41(12):974–980. doi:10.1016/j.clinbiochem.2008.05.005
   PubMed Web of Science ®Google Scholar
• Riedemann NC, Guo RF, Bernacki KD, et al. Regulation by C5a of neutrophil activation during sepsis. Immunity. 2003;19(2):193–202. doi:10.1016/S1074-7613(03)00206-1
   PubMed Web of Science ®Google Scholar
• Xu D, Hou S, Jiang Y, et al. Complement C5 gene confers risk for acute anterior uveitis. Invest Ophthalmol Vis Sci. 2015;56(8):4954–4960. doi:10.1167/iovs.15-16645
   PubMed Web of Science ®Google Scholar
• Wu H, Weng Y, Zheng L, et al. Polymorphism of the complement 5 gene is associated with large artery atherosclerosis stroke in Chinese patients. Arq Neuropsiquiatr. 2016;74(11):881–886. doi:10.1590/0004-282x20160139
   PubMed Web of Science ®Google Scholar
• Hoke M, Speidl W, Schillinger M, et al. Polymorphism of the complement 5 gene and cardiovascular outcome in patients with atherosclerosis. Eur J Clin Invest. 2012;42(9):921–926. doi:10.1111/j.1365-2362.2012.02669.x
   PubMed Web of Science ®Google Scholar
• Yan C, Gao H. New insights for C5a and C5a receptors in sepsis. Front Immunol. 2012;3:368. doi:10.3389/fimmu.2012.00368
   PubMed Web of Science ®Google Scholar
• Ward PA. Role of C5 activation products in sepsis. Sci World J. 2010;10:2395–2402. doi:10.1100/tsw.2010.216
   Google Scholar
• Guo RF, Riedemann NC, Ward PA. Role of C5a-C5aR interaction in sepsis. Shock. 2004;21(1):1–7. doi:10.1097/01.shk.0000105502.75189.5e
   PubMed Web of Science ®Google Scholar
• Höpken U, Mohr M, Strüber A, et al. Inhibition of interleukin-6 synthesis in an animal model of septic shock by anti-C5a monoclonal antibodies. Eur J Immunol. 1996;26(5):1103–1109. doi:10.1002/eji.1830260522
   PubMed Web of Science ®Google Scholar
• Riedemann NC, Guo RF, Hollmann TJ, et al. Regulatory role of C5a in LPS-induced IL-6 production by neutrophils during sepsis. FASEB J. 2004;18(2):370–372. doi:10.1096/fj.03-0708fje
   PubMed Web of Science ®Google Scholar
• Khameneh HJ, Ho AW, Laudisi F, et al. C5a regulates IL-1β production and leukocyte recruitment in a murine model of monosodium urate crystal-induced peritonitis. Front Pharmacol. 2017;8:10. doi:10.3389/fphar.2017.00010
   PubMed Web of Science ®Google Scholar
• Seow V, Lim J, Iyer A, et al. Inflammatory responses induced by lipopolysaccharide are amplified in primary human monocytes but suppressed in macrophages by complement protein C5a. J Immunol. 2013;191(8):4308–4316. doi:10.4049/jimmunol.1301355
   PubMed Web of Science ®Google Scholar
• Ehrnström B, Kojen JF, Giambelluca M, et al. TLR8 and complement C5 induce cytokine release and thrombin activation in human whole blood challenged with gram-positive bacteria. J Leukoc Biol. 2020;107(4):673–683. doi:10.1002/JLB.3A0120-114R
   PubMed Web of Science ®Google Scholar